Table 3. Differential counts at the time of at least major molecular response (MMR).
| absolute numbers (G/L) |
reference values (G/L) |
relative numbers (%) |
reference values (%) |
|
|---|---|---|---|---|
| Neutrophils | 2.87±0.84 | 2.0-7.5 | 57.61±9.40 | 50-75 |
| Lymphocytes | 1.51±0.50 | 1.0-4.0 | 31.13±8.85 | 25-40 |
| Monocytes | 0.36±0.15 | 0.0-1.2 | 7.43±2.74 | 0-12 |
| Eosinophils | 0.17±0.17 | 0.0-0.4 | 3.30±2.98 | 0-4 |
| Basophils | 0.03±0.04 | 0.0-0.1 | 0.47±0.67 | 0.0-1.0 |
Leukocyte counts were determine in all CML patients (n=23) before the start of therapy with imatinib and during therapy at the time of (at least) MMR. Differential counts were examined on Wright-Giemsa-stained blood smears.